Home >
Medicine Info >
Eglucent Mix 25 Kwikpen
Loading interface...

Eglucent Mix 25 Kwikpen

Manufactured byLUPIN LTD
ContainsInsulin Lispro (25 International units ) + Insulin Lispro Protamine (75 International units )
Description
Eglucent Mix 25 Kwikpen is a combination of fast-acting and intermediate-acting analogs of insulin (a natural substance produced by the pancreas which helps in utilizing sugar for energy production). This medicine is used in the treatment of Diabetes Mellitus (high blood sugar levels). It helps in the utilisation of sugar for energy and also reduces the production of sugar by the liver, thus helping to control your blood sugar levels. Eglucent Mix 25 Kwikpen has some side effects like weight gain, constipation, redness/swelling/itching at the site of injection, etc. It may result in low blood sugar levels and you may feel hungry, irritable, dizzy, anxious, or shaky. It is always recommended to eat or drink a fast-acting source of sugar (fruit juice, candy, raisins, etc.) to quickly treat these symptoms. However, consult your doctor if these symptoms bother you for a longer time or worsen. Avoid using this medicine if you are allergic to it. Eglucent Mix 25 Kwikpen should be administered as instructed by your doctor. Your doctor or nurse will demonstrate the safe and proper method to administer the medicine. It is usually administered 15 minutes before a meal or immediately after a meal. Avoid the discontinuation of treatment without consulting your doctor, as it may cause an increase in blood sugar levels and lead to further complications. Eglucent Mix 25 Kwikpen may not be suitable for all. Inform your doctor if you have a low blood potassium level, or kidney or liver problems. Also, inform your doctor about all your ongoing medications. Consult your doctor if you are pregnant or breastfeeding before using this medicine.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Eglucent Mix 25 Kwikpen

  • Decreased blood glucose levels
  • Tingling of hands or feet
  • Dry mouth
  • Sore throat
  • Headache
  • Weight gain
  • Pain at the injection site
  • Dizziness
  • Confusion

Uses of Eglucent Mix 25 Kwikpen

What is it prescribed for?

  • Type I Diabetes mellitus
  • Type II Diabetes Mellitus
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of Eglucent Mix 25 Kwikpen can be observed within 10-20 minutes of administration of the dose.
  • How long do the effects of this medicine last?
    The effect of Eglucent Mix 25 Kwikpen lasts for an average duration of 18 to 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with Eglucent Mix 25 Kwikpen as it may alter your blood sugar levels.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Eglucent Mix 25 Kwikpen.
  • Can this medicine be taken during pregnancy?
    Eglucent Mix 25 Kwikpen should be used during pregnancy upon your doctor's recommendation.
  • Can this medicine be taken while breast-feeding?
    Eglucent Mix 25 Kwikpen is considered safe for use while breastfeeding upon your doctor's recommendation.

Allergy

Eglucent Mix 25 Kwikpen is not recommended for use if you are allergic to it. Serious allergic reactions to this medicine are rare. However, seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.

Hypoglycaemia

Hypoglycemia is low blood sugar levels. Eglucent Mix 25 Kwikpen is not recommended for use if you have hypoglycaemia as it may worsen your condition.
Warnings for special population

Pregnancy

Eglucent Mix 25 Kwikpen should be used during pregnancy upon your doctor's recommendation.

Breast-feeding

Eglucent Mix 25 Kwikpen is considered safe for use while breastfeeding upon your doctor's recommendation.
General warnings

Oedema

Oedema is fluid retention in your body. Eglucent Mix 25 Kwikpen should be used with caution as it may cause oedema in some cases.

Hypoglycaemia

Hypoglycemia is low blood sugar levels. Eglucent Mix 25 Kwikpen may cause hypoglycaemia in some cases. This risk is especially higher if you have kidney problems, are malnourished, or taking any other medication that may lower blood sugar levels. Your doctor may recommend that you check your blood sugar levels regularly during treatment with Eglucent Mix 25 Kwikpen.

Driving and operating machines

Your ability to drive vehicles or operate machines may be affected due to low or high blood sugar levels. Hence, avoid activities that require mental alertness if you experience symptoms such as dizziness, blurred vision, etc., during treatment with Eglucent Mix 25 Kwikpen.

Use with other insulin

Eglucent Mix 25 Kwikpen should not be diluted or mixed with any other insulin solution, as it may alter the effects of either medicine when administered together and/or increase the risk of side effects.

Single person use

Never share Eglucent Mix 25 Kwikpen with others, as it may lead to the transfer of infection or disease from one person to another.

Allergic reactions at the injection site

Injection site reactions that may occur with the use of Eglucent Mix 25 Kwikpen include redness, pain, itching, swelling, or hives (itchy, painful eruptions that sting). Continuous rotation of the injection site within a given area is recommended to help reduce or prevent these reactions. These reactions usually resolve within a few days to a few weeks.

Use in children

Eglucent Mix 25 Kwikpen is not recommended for use in children below 18 years of age as the safety and efficacy data are not clinically established.

Subcutaneous use only

Eglucent Mix 25 Kwikpen is meant for subcutaneous (under the skin) administration only. It should not be administered intravenously (into the veins) or intramuscularly (into the muscles).

Missed Dose

Eglucent Mix 25 Kwikpen must be administered 20 minutes before a meal or immediately after a meal. If you remember that you have missed a dose shortly after a meal, inject it immediately. However, if much time has passed since you had your food, follow the instruction given by your doctor. Do not inject a double dose to make up for the missed dose.

Overdose

Seek immediate medical attention if an overdose of Eglucent Mix 25 Kwikpen is suspected. Hypoglycaemia (low blood sugar levels) may occur in case of an overdose with symptoms such as extreme weakness, blurred vision, sweating, trouble speaking, tremors, stomach pain, confusion, etc.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with Eglucent Mix 25 Kwikpen as it may alter your blood sugar levels.
Interaction with Medicine

Benazepril

Prednisone

Aspirin

Enalapril

Disease interactions

Kidney Disease

Eglucent Mix 25 Kwikpen should be used with caution if you have kidney problems as it may increase the risk of side effects. Your doctor may suggest close monitoring of your blood sugar levels and/or recommend appropriate dose adjustments based on your clinical condition.

Hypokalaemia

Eglucent Mix 25 Kwikpen should be used with caution as it may increase the risk of hypokalaemia (low blood potassium levels). Your doctor may suggest tests to monitor your blood potassium levels periodically while on treatment with this medicine.

Liver Disease

Eglucent Mix 25 Kwikpen should be used with caution if you have liver problems as it may increase the risk of undesired effects. Your doctor may recommend appropriate dose adjustments based on your clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Administer Eglucent Mix 25 Kwikpen as instructed by your doctor. Carefully follow all the instructions given by your doctor. This medicine is injected under the skin. Do not inject into the skin area that is damaged, tender, bruised, thickened, or has a scar or hard lumps. Rotate or switch your injection sites regularly to prevent skin damage. Do not administer Eglucent Mix 25 Kwikpen in larger or smaller amounts than prescribed. Consult your doctor if you experience any undesirable effects that persist or worsen. Keep a check on your blood sugar levels regularly. Plan frequent follow-up visits with your doctor so that he/she may monitor your condition. Never share an injection pen, cartridge, or syringe with another person, even if the needle has been changed.
Miscelleneous

To be taken before food

To be taken as instructed by doctor

May cause sleepiness

How it works
Eglucent Mix 25 Kwikpen works by enhancing the sugar uptake from the blood into the body tissues and also by preventing the production of sugar in the liver. Thus, it helps to control high blood sugar levels.
Legal Status

Unknown

Approved

Unknown

Approved

Classification

Category

Insulin, Insulin analog combination, Antidiabetic agents

Schedule

Schedule H

Drugs, H., 2021. Insulin Lispro Injection: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: [Accessed 21 December 2021].

https://medlineplus.gov/druginfo/meds/a697021.html#side-effects

Dailymed.nlm.nih.gov. 2022. DailyMed. [online] Available at: [Accessed 14 July 2022].

https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=c73da51a-1899-45ad-b6cf-9c52c36a25dd&type=display

Medicines.org.uk. 2022. Humalog Mix25 100 units/ml KwikPen, suspension for injection in a pre-filled pen - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: [Accessed 14 July 2022].

https://www.medicines.org.uk/emc/product/7475/smpc
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 16 Sep 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.